Sign In
Buy ANIX
$3.42
-0.140 (-3.93%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Enz
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference
12:00pm, Monday, 02'nd Mar 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data related to Anixa's recently launch
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
12:00pm, Wednesday, 12'th Feb 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that the research team lead by Dr. Jose Cone
Top Ranked Momentum Stocks to Buy for February 11th
12:16pm, Tuesday, 11'th Feb 2020
Top Ranked Momentum Stocks to Buy for February 11th
Top Ranked Momentum Stocks to Buy for February 11th
12:16pm, Tuesday, 11'th Feb 2020
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 11th.
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter Int
Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference
12:00pm, Monday, 06'th Jan 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from studies utilizing Cchek™, t
Investors Who Bought Anixa Biosciences (NASDAQ:ANIX) Shares Three Years Ago Are Now Down 38%
10:25am, Thursday, 02'nd Jan 2020
It's nice to see the Anixa Biosciences, Inc. (NASDAQ:ANIX) share price up 14% in a week. But that cannot eclipse the...
Anixa Biosciences to Present at Biotech Showcase 2020
12:00pm, Monday, 23'rd Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that its chief executive officer, Dr. Amit K
Anixa Biosciences Announces Commercial Launch of Cchek™ Prostate Cancer Confirmatory Test
11:45am, Monday, 16'th Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the commercial launch of its Cchek™ Prosta
Anixa Biosciences to Host Conference Call to Discuss Plans for 2020
10:45pm, Friday, 13'th Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that it will hold a conference call on Decem
